Author:
Fatica Erica M.,Martinez Mark,Ladwig Paula M.,Murray Josiah D.,Kohlhagen Mindy C.,Kyle Robert A.,Kourelis Taxiarchis,Lust John A.,Snyder Melissa R.,Dispenzieri Angela,Murray David L.,Willrich Maria A.V.
Subject
Clinical Biochemistry,General Medicine
Reference30 articles.
1. Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma;Wadhera;Blood.,2011
2. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias;Zou;Biol. Blood Marrow Transplant.,2014
3. Clinical characteristics and outcomes in biclonal gammopathies;Mullikin;Am. J. Hematol.,2016
4. A double monoclonal IgG1 kappa and IgG2 kappa in a single myeloma patient. Variation in clonal products and therapeutic responses;Goni;J. Immunol.,1988
5. Pizzolato, Bragantini, Bresciani, Pavlovsky, Chuba, Vidal, Rostagno, Ghiso, IgG1-κ biclonal gammopathy associated with multiple myeloma suggests a regulatory mechanism, Br. J. Haematol. 102 (1998) 503–508. 10.1046/j.1365-2141.1998.00805.x.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献